The Cooper Companies, Inc. (COO): Price and Financial Metrics

The Cooper Companies, Inc. (COO)

Today's Latest Price: $334.61 USD

0.57 (0.17%)

Updated Dec 2 7:00pm

Add COO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

COO Stock Summary

  • COO has a market capitalization of $17,817,827,550 -- more than approximately 89.06% of US stocks.
  • Cooper Companies Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.95% of US equities in our set.
  • In terms of volatility of its share price, COO is more volatile than just 8.3% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cooper Companies Inc are XYL, STE, TFX, CBRE, and FTV.
  • COO's SEC filings can be seen here. And to visit Cooper Companies Inc's official web site, go to

COO Stock Price Chart Interactive Chart >

Price chart for COO

COO Price/Volume Stats

Current price $334.61 52-week high $371.59
Prev. close $334.04 52-week low $236.68
Day low $331.12 Volume 206,604
Day high $335.79 Avg. volume 322,148
50-day MA $339.67 Dividend yield 0.02%
200-day MA $310.35 Market Cap 17.85B

The Cooper Companies, Inc. (COO) Company Bio

The Cooper Companies operates through two business units. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. The company was founded in 1980 and is based in Pleasanton, California.

COO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$334.61$24.85 -93%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Cooper Companies Inc. To summarize, we found that Cooper Companies Inc ranked in the 9th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Cooper Companies Inc, consider:

  • The company's debt burden, as measured by earnings divided by interest payments, is 7.73; that's higher than 64.81% of US stocks in the Healthcare sector that have positive free cash flow.
  • Its compound free cash flow growth rate, as measured over the past 5.5 years, is -0.04% -- higher than only 19.84% of stocks in our DCF forecasting set.
  • COO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 32.62% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

EW, SXTC, TEVA, BHC, and LUMO can be thought of as valuation peers to COO, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

COO Latest News Stream

Event/Time News Detail
Loading, please wait...

COO Latest Social Stream

Loading social stream, please wait...

View Full COO Social Stream

Latest COO News From Around the Web

Below are the latest news stories about Cooper Companies Inc that investors may wish to consider to help them evaluate COO as an investment opportunity.

The Cooper Companies, Inc. (COO) CEO Al White on Q3 2020 Results - Earnings Call Transcript

The Cooper Companies, Inc. (COO) Q3 2020 Results Conference Call September 03, 2020 05:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations and Risk Management Al White - President & Chief Executive Officer Brian Andrews - Chief Financial Officer and Treasurer Conference Call Participants Larry Keusch -...

SA Transcripts on Seeking Alpha | September 4, 2020

Precipio, AnPac Bio-Medical Science leads the gainers pack, Cardiff Oncology, Fulgent Genetics amongst major losers

Gainers: Precipio (NASDAQ:PRPO) +15%, AnPac Bio-Medical Science Co ANPC +15%, The Cooper Companies (NYSE:COO) +7%, Entasis Therapeutics Holdings (NASDAQ:ET

Seeking Alpha | September 4, 2020

The Cooper Companies FQ3 2020 Earnings Preview

The Cooper Companies (NYSE:COO) is scheduled to announce FQ3 earnings results on Thursday, September 3rd, after market close.The consensus EPS Estimate is $1.54 (-52.3% Y/Y) and the consensus Revenue Estimate is $536.11M (-21.1% Y/Y).Over the last 2 years, COO has beaten EPS estimates 50% of the time and has beaten...

Seeking Alpha | September 2, 2020

Did Hedge Funds Make The Right Call On The Cooper Companies, Inc. (COO) ?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | July 20, 2020

Top Insider Buys Highlight for the Week of July 10

Insiders load up on Dun & Bradstreet, Syneos Health, Sunnova Energy International and The Cooper Companies Continue reading...

Yahoo | July 11, 2020

Read More 'COO' Stories Here

COO Price Returns

1-mo 4.40%
3-mo 9.06%
6-mo 5.06%
1-year 7.47%
3-year 40.62%
5-year 157.06%
YTD 4.17%
2019 26.27%
2018 16.84%
2017 24.59%
2016 30.40%
2015 -17.18%

COO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full COO Dividend History

Continue Researching COO

Want to see what other sources are saying about Cooper Companies Inc's financials and stock price? Try the links below:

Cooper Companies Inc (COO) Stock Price | Nasdaq
Cooper Companies Inc (COO) Stock Quote, History and News - Yahoo Finance
Cooper Companies Inc (COO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9058 seconds.